Continuing education program (CME) 2022 of the Ho Chi Minh City Rheumatology Association on October 22, 2022 at Thong Nhat Hospital. The conference gathered 200 delegates who are doctors specializing in Musculoskeletal and Joint Diseases.
Annually accompanying the Ho Chi Minh City Rheumatology Association, Medbolide Joint Stock Company participated in sponsoring the Conference with a booth introducing Musculoskeletal and Joint products VOCFOR (Lornoxicam 4mg), CAPSER (Capsaicin 0.075%), TAMDEFLO (Deflazacort 6mg), DEGODAS (Ibandronat 2.5mg), BIROMONOL (Carisoprodol 350mg). At the booth, representatives of Medbolide Company welcomed and discussed in more depth with doctors about the safety, effectiveness and outstanding advantages of the products.
Medbolide Company always wants to accompany the Ho Chi Minh City Rheumatology Association in updating the latest knowledge, and affirms that it will continue its efforts to create the best quality medicinal products to serve public health.